Australia markets closed

Apellis Pharmaceuticals, Inc. (APLS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
44.19-3.65 (-7.63%)
At close: 04:00PM EDT
44.62 +0.43 (+0.97%)
Pre-market: 04:23AM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts14151413
Avg. Estimate-0.53-0.38-1.251.08
Low estimate-0.83-0.6-2.18-0.76
High estimate-0.280.090.462.28
Year ago EPS-1.56-1.02-4.45-1.25
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts16161615
Avg. Estimate162.12M185.71M787.45M1.17B
Low estimate137.45M162.63M701.5M877.2M
High estimate178.58M228.28M919.78M1.57B
Year ago sales44.85M70.25M396.59M787.45M
Sales growth (year/est)261.50%164.40%98.60%48.50%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-1.46-1.32-0.85-0.69
Actual EPS-1.56-1.02-1.17-0.73
Difference-0.10.3-0.32-0.04
Surprise %-6.80%22.70%-37.60%-5.80%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.53-0.38-1.251.08
7 days ago-0.54-0.37-1.231.2
30 days ago-0.54-0.37-1.21.2
60 days ago-0.55-0.39-1.121.44
90 days ago-0.55-0.4-1.321.27
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days3331
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/A11
Growth estimatesAPLSIndustrySector(s)S&P 500
Current qtr.66.00%N/AN/AN/A
Next qtr.62.70%N/AN/AN/A
Current year71.90%N/AN/AN/A
Next year186.40%N/AN/AN/A
Next 5 years (per annum)33.30%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A